Botox Cosmetic
Allergan Aesthetics, an AbbVie company
glabella, forehead, lateral canthal lines, platysma bands
Botox vs. dermal fillers
Last verified 7/30/2026
These treatments work differently and are not direct substitutes.
Hyaluronic acid dermal fillers
Injectable
lips, perioral lines, cheeks, chin, jawline, nasolabial folds, temples, infraorbital hollow, dorsal hands
Quick comparison
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| Treatment category | Injectable | Injectable |
| What it targets | Movement-driven lines and the pull of specifically injected muscles. | Volume, contour, projection, and selected folds or hollows when an appropriately indicated product is placed in the intended tissue plane. |
| How it works | Binds to motor nerve terminals and inhibits acetylcholine release by cleaving SNAP-25, producing temporary chemodenervation of injected muscles. | An implanted hyaluronic acid gel occupies space in soft tissue; formulation, cross-linking, concentration, particle properties, and injection plane differ by product. |
| Common treatment areas | glabella, forehead, lateral canthal lines, platysma bands | lips, perioral lines, cheeks, chin, jawline, nasolabial folds, temples, infraorbital hollow, dorsal hands |
| Whether it adds volume | No | Yes |
| Results timing | An effect can begin within 1 to 2 days and commonly strengthens during the first week. | Volume change is visible immediately, with assessment refined after early swelling settles. |
| Typical longevity | The FDA label describes approximately 3 to 4 months for glabellar-line effect; individual areas and patients vary. | Product- and area-specific. FDA consumer guidance gives roughly 6 to 12 months for many absorbable HA fillers, while some approved products have longer study follow-up. |
| Reversibility | Not immediately reversible; the effect usually diminishes as neuromuscular function recovers. | Many HA fillers can often be reduced with clinician-administered hyaluronidase, but this use is off-label in the US, response varies, and complete reversal is not guaranteed. |
| Downtime | No required recovery period is specified in the label, although injection-site effects can occur. | Usually limited social downtime, but swelling, tenderness, redness, and bruising can be conspicuous for days and sometimes longer. |
| Pricing basis | Usually priced per Botox Cosmetic unit or, less transparently, by treatment area; Botox units must not be converted to Dysport units. | Usually priced per syringe or mL; price comparisons must retain product, syringe volume, area, and whether multiple syringes are expected. |
| Major risks | Unwanted weakness such as eyelid or brow ptosis, asymmetry, headache, hypersensitivity, and rare distant spread of toxin effect with swallowing or breathing difficulty. Contraindicated with hypersensitivity to a botulinum toxin preparation or infection at the injection site. | Swelling, bruising, pain, tenderness, lumps, infection, inflammatory reactions, and rare inadvertent intravascular injection causing tissue necrosis, vision loss, or stroke. |
| Primary limitations | Static etched lines or volume loss can remain even when muscle movement is reduced. | The wrong product, amount, or placement can look overfilled, fail to address the actual cause, or require more than one syringe. |
Treatment category
- Botox Cosmetic
- Injectable
- Hyaluronic acid dermal fillers
- Injectable
What it targets
- Botox Cosmetic
- Movement-driven lines and the pull of specifically injected muscles.
- Hyaluronic acid dermal fillers
- Volume, contour, projection, and selected folds or hollows when an appropriately indicated product is placed in the intended tissue plane.
How it works
- Botox Cosmetic
- Binds to motor nerve terminals and inhibits acetylcholine release by cleaving SNAP-25, producing temporary chemodenervation of injected muscles.
- Hyaluronic acid dermal fillers
- An implanted hyaluronic acid gel occupies space in soft tissue; formulation, cross-linking, concentration, particle properties, and injection plane differ by product.
Common treatment areas
- Botox Cosmetic
- glabella, forehead, lateral canthal lines, platysma bands
- Hyaluronic acid dermal fillers
- lips, perioral lines, cheeks, chin, jawline, nasolabial folds, temples, infraorbital hollow, dorsal hands
Whether it adds volume
- Botox Cosmetic
- No
- Hyaluronic acid dermal fillers
- Yes
Results timing
- Botox Cosmetic
- An effect can begin within 1 to 2 days and commonly strengthens during the first week.
- Hyaluronic acid dermal fillers
- Volume change is visible immediately, with assessment refined after early swelling settles.
Typical longevity
- Botox Cosmetic
- The FDA label describes approximately 3 to 4 months for glabellar-line effect; individual areas and patients vary.
- Hyaluronic acid dermal fillers
- Product- and area-specific. FDA consumer guidance gives roughly 6 to 12 months for many absorbable HA fillers, while some approved products have longer study follow-up.
Reversibility
- Botox Cosmetic
- Not immediately reversible; the effect usually diminishes as neuromuscular function recovers.
- Hyaluronic acid dermal fillers
- Many HA fillers can often be reduced with clinician-administered hyaluronidase, but this use is off-label in the US, response varies, and complete reversal is not guaranteed.
Downtime
- Botox Cosmetic
- No required recovery period is specified in the label, although injection-site effects can occur.
- Hyaluronic acid dermal fillers
- Usually limited social downtime, but swelling, tenderness, redness, and bruising can be conspicuous for days and sometimes longer.
Pricing basis
- Botox Cosmetic
- Usually priced per Botox Cosmetic unit or, less transparently, by treatment area; Botox units must not be converted to Dysport units.
- Hyaluronic acid dermal fillers
- Usually priced per syringe or mL; price comparisons must retain product, syringe volume, area, and whether multiple syringes are expected.
Major risks
- Botox Cosmetic
- Unwanted weakness such as eyelid or brow ptosis, asymmetry, headache, hypersensitivity, and rare distant spread of toxin effect with swallowing or breathing difficulty. Contraindicated with hypersensitivity to a botulinum toxin preparation or infection at the injection site.
- Hyaluronic acid dermal fillers
- Swelling, bruising, pain, tenderness, lumps, infection, inflammatory reactions, and rare inadvertent intravascular injection causing tissue necrosis, vision loss, or stroke.
Primary limitations
- Botox Cosmetic
- Static etched lines or volume loss can remain even when muscle movement is reduced.
- Hyaluronic acid dermal fillers
- The wrong product, amount, or placement can look overfilled, fail to address the actual cause, or require more than one syringe.
Benefits and trade-offs
Botox Cosmetic
- Movement-driven lines and the pull of specifically injected muscles.
- It does not add tissue volume, replace structural support, fill a hollow, or resurface skin.
- Static etched lines or volume loss can remain even when muscle movement is reduced.
Hyaluronic acid dermal fillers
- Volume, contour, projection, and selected folds or hollows when an appropriately indicated product is placed in the intended tissue plane.
- It does not reduce muscle contraction like a neuromodulator and is not a skin-resurfacing treatment.
- The wrong product, amount, or placement can look overfilled, fail to address the actual cause, or require more than one syringe.
Details
Open a section for more context. Sources appear beside the claims they support.
Purpose and mechanism
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| How it works | Binds to motor nerve terminals and inhibits acetylcholine release by cleaving SNAP-25, producing temporary chemodenervation of injected muscles.
| An implanted hyaluronic acid gel occupies space in soft tissue; formulation, cross-linking, concentration, particle properties, and injection plane differ by product. |
| What it primarily changes | Movement-driven lines and the pull of specifically injected muscles.
| Volume, contour, projection, and selected folds or hollows when an appropriately indicated product is placed in the intended tissue plane. |
| What it does not change | It does not add tissue volume, replace structural support, fill a hollow, or resurface skin.
| It does not reduce muscle contraction like a neuromodulator and is not a skin-resurfacing treatment. |
| Adds volume | No
| Yes |
| Tightening effect | None; any contour change comes from altered muscle pull, not tissue tightening.
| No direct tissue-tightening action; contour support can create a lifted appearance in selected anatomy. |
| Whether they are true substitutes | Botox and Dysport share a treatment class but have different labels and non-interchangeable potency units. Botox and fillers are different approaches.
| HA fillers may be substitutes only when two specific products are intended for the same area and plane. They are a different approach from Botox. |
How it works
- Botox Cosmetic
- Binds to motor nerve terminals and inhibits acetylcholine release by cleaving SNAP-25, producing temporary chemodenervation of injected muscles.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- An implanted hyaluronic acid gel occupies space in soft tissue; formulation, cross-linking, concentration, particle properties, and injection plane differ by product.
What it primarily changes
- Botox Cosmetic
- Movement-driven lines and the pull of specifically injected muscles.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Volume, contour, projection, and selected folds or hollows when an appropriately indicated product is placed in the intended tissue plane.
What it does not change
- Botox Cosmetic
- It does not add tissue volume, replace structural support, fill a hollow, or resurface skin.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- It does not reduce muscle contraction like a neuromodulator and is not a skin-resurfacing treatment.
Adds volume
Tightening effect
- Botox Cosmetic
- None; any contour change comes from altered muscle pull, not tissue tightening.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- No direct tissue-tightening action; contour support can create a lifted appearance in selected anatomy.
Whether they are true substitutes
- Botox Cosmetic
- Botox and Dysport share a treatment class but have different labels and non-interchangeable potency units. Botox and fillers are different approaches.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- HA fillers may be substitutes only when two specific products are intended for the same area and plane. They are a different approach from Botox.
Sessions, downtime and recovery
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| Typical number of sessions | One treatment visit; repeat treatment is considered after the effect wanes and should follow the product label.
| Often one visit with possible staged treatment or touch-up; amount and number of sessions depend on product, area, and goal. |
| Downtime | No required recovery period is specified in the label, although injection-site effects can occur.
| Usually limited social downtime, but swelling, tenderness, redness, and bruising can be conspicuous for days and sometimes longer.
|
| Swelling | Localized swelling is possible.
| Common and product/area dependent; lips can swell substantially.
|
Typical number of sessions
- Botox Cosmetic
- One treatment visit; repeat treatment is considered after the effect wanes and should follow the product label.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Often one visit with possible staged treatment or touch-up; amount and number of sessions depend on product, area, and goal.
Downtime
- Botox Cosmetic
- No required recovery period is specified in the label, although injection-site effects can occur.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Usually limited social downtime, but swelling, tenderness, redness, and bruising can be conspicuous for days and sometimes longer.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Swelling
- Botox Cosmetic
- Localized swelling is possible.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Common and product/area dependent; lips can swell substantially.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Longevity and reversibility
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| How long it lasts | The FDA label describes approximately 3 to 4 months for glabellar-line effect; individual areas and patients vary.
| Product- and area-specific. FDA consumer guidance gives roughly 6 to 12 months for many absorbable HA fillers, while some approved products have longer study follow-up.
|
| Reversibility | Not immediately reversible; the effect usually diminishes as neuromuscular function recovers.
| Many HA fillers can often be reduced with clinician-administered hyaluronidase, but this use is off-label in the US, response varies, and complete reversal is not guaranteed.
|
How long it lasts
- Botox Cosmetic
- The FDA label describes approximately 3 to 4 months for glabellar-line effect; individual areas and patients vary.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Product- and area-specific. FDA consumer guidance gives roughly 6 to 12 months for many absorbable HA fillers, while some approved products have longer study follow-up.
- FDA-Approved Dermal Fillers · fda.gov
Reversibility
- Botox Cosmetic
- Not immediately reversible; the effect usually diminishes as neuromuscular function recovers.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Many HA fillers can often be reduced with clinician-administered hyaluronidase, but this use is off-label in the US, response varies, and complete reversal is not guaranteed.
- The use of hyaluronidase in aesthetic practice · pmc.ncbi.nlm.nih.gov
Risks and limitations
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| Documented risks | Unwanted weakness such as eyelid or brow ptosis, asymmetry, headache, hypersensitivity, and rare distant spread of toxin effect with swallowing or breathing difficulty. Contraindicated with hypersensitivity to a botulinum toxin preparation or infection at the injection site.
| Swelling, bruising, pain, tenderness, lumps, infection, inflammatory reactions, and rare inadvertent intravascular injection causing tissue necrosis, vision loss, or stroke.
|
| Most likely disappointment | Static etched lines or volume loss can remain even when muscle movement is reduced.
| The wrong product, amount, or placement can look overfilled, fail to address the actual cause, or require more than one syringe. |
| When this treatment may not be appropriate | Do not use with product hypersensitivity or infection at the proposed injection site; additional warnings and patient-specific exclusions require prescriber review.
| Avoid when product contraindications apply, at infected or inflamed sites, or when the goal requires muscle relaxation, skin resurfacing, or surgery rather than volume.
|
| Provider-dependent variables | Muscle assessment, injection sites, dose, depth, symmetry planning, and management of adjacent-muscle spread.
| Diagnosis, product selection, injection plane, amount, cannula or needle choice, vascular safety technique, and complication readiness.
|
| Skin-tone considerations | Filler is not selected by skin tone alone, but bruising, inflammation, and post-inflammatory pigment change may present differently; product labelling and injector experience still matter.
|
Documented risks
- Botox Cosmetic
- Unwanted weakness such as eyelid or brow ptosis, asymmetry, headache, hypersensitivity, and rare distant spread of toxin effect with swallowing or breathing difficulty. Contraindicated with hypersensitivity to a botulinum toxin preparation or infection at the injection site.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Swelling, bruising, pain, tenderness, lumps, infection, inflammatory reactions, and rare inadvertent intravascular injection causing tissue necrosis, vision loss, or stroke.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Most likely disappointment
- Botox Cosmetic
- Static etched lines or volume loss can remain even when muscle movement is reduced.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- The wrong product, amount, or placement can look overfilled, fail to address the actual cause, or require more than one syringe.
When this treatment may not be appropriate
- Botox Cosmetic
- Do not use with product hypersensitivity or infection at the proposed injection site; additional warnings and patient-specific exclusions require prescriber review.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Avoid when product contraindications apply, at infected or inflamed sites, or when the goal requires muscle relaxation, skin resurfacing, or surgery rather than volume.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Provider-dependent variables
- Botox Cosmetic
- Muscle assessment, injection sites, dose, depth, symmetry planning, and management of adjacent-muscle spread.
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- Diagnosis, product selection, injection plane, amount, cannula or needle choice, vascular safety technique, and complication readiness.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Skin-tone considerations
- Botox Cosmetic
- Hyaluronic acid dermal fillers
- Filler is not selected by skin tone alone, but bruising, inflammation, and post-inflammatory pigment change may present differently; product labelling and injector experience still matter.
- FDA: Dermal Filler Do's and Don'ts · fda.gov
Evidence and regulatory status
| Attribute | Botox Cosmetic | Hyaluronic acid dermal fillers |
|---|---|---|
| United States regulatory status | FDA-approved prescription biologic for temporary improvement of moderate to severe glabellar lines, lateral canthal lines, forehead lines, and platysma bands in adults under the current US label.
| The FDA approves dermal fillers product by product and for specific indications; the HA-filler class itself is not a single approved product.
|
| Canadian regulatory status | Health Canada Drug Product Database lists Botox Cosmetic DIN 02531445 as approved; Canadian indications and dosing must follow the current Canadian product monograph.
| Health Canada licenses HA filler devices product by product through MDALL for Class III devices; class-level status does not establish a licence for every brand or indication. |
| Evidence status | High for product identity, mechanism, labelled indications, contraindications, and labelled duration; outcomes remain dose-, area-, and patient-dependent.
| High for class mechanism, product-specific regulatory model, common reactions, and vascular risk; duration and suitability must remain product- and area-specific.
|
United States regulatory status
- Botox Cosmetic
- FDA-approved prescription biologic for temporary improvement of moderate to severe glabellar lines, lateral canthal lines, forehead lines, and platysma bands in adults under the current US label.
- BOTOX Cosmetic prescribing information · accessdata.fda.gov
- FDA approval letter for BOTOX Cosmetic · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- The FDA approves dermal fillers product by product and for specific indications; the HA-filler class itself is not a single approved product.
- FDA-Approved Dermal Fillers · fda.gov
Canadian regulatory status
- Botox Cosmetic
- Health Canada Drug Product Database lists Botox Cosmetic DIN 02531445 as approved; Canadian indications and dosing must follow the current Canadian product monograph.
- Health Canada Drug Product Database: Botox Cosmetic DIN 02531445 · health-products.canada.ca
- Hyaluronic acid dermal fillers
- Health Canada licenses HA filler devices product by product through MDALL for Class III devices; class-level status does not establish a licence for every brand or indication.
Evidence status
- Botox Cosmetic
- High for product identity, mechanism, labelled indications, contraindications, and labelled duration; outcomes remain dose-, area-, and patient-dependent.
- FDA approval letter for BOTOX Cosmetic · accessdata.fda.gov
- Hyaluronic acid dermal fillers
- High for class mechanism, product-specific regulatory model, common reactions, and vascular risk; duration and suitability must remain product- and area-specific.
- FDA-Approved Dermal Fillers · fda.gov
SourcesShowHide
Sources are grouped by treatment so the support for each record stays visible.
Botox Cosmetic
- BOTOX Cosmetic prescribing information · accessdata.fda.gov
- BOTOX Cosmetic US Prescribing Information · accessdata.fda.gov, 2024-10-18 · supports 23 fields
- FDA approval letter for BOTOX Cosmetic · accessdata.fda.gov, 2002-04-12 · supports 2 fields
- Health Canada Drug Product Database: Botox Cosmetic DIN 02531445 · health-products.canada.ca, 2025-04-09
Hyaluronic acid dermal fillers
- FDA-Approved Dermal Fillers · fda.gov · supports 3 fields
- FDA: Dermal Filler Do's and Don'ts · fda.gov · supports 7 fields
- FDA: Dermal Fillers (Soft Tissue Fillers) · fda.gov · supports 15 fields
- Health Canada Medical Devices Active Licence Listing · canada.ca
- The use of hyaluronidase in aesthetic practice · pmc.ncbi.nlm.nih.gov, 2018-01-01
See average treatment prices near you
Enter a US ZIP code or Canadian postal code to check our stored estimate for the surrounding market.